da Silva Lima, Natália
Cabaleiro, Alba
Novoa, Eva
Riobello, Cristina
Knerr, Patrick J.
He, Yantao
Esquinas-Román, Eva M.
González-García, Ismael
Prevot, Vincent
Schwaninger, Markus
Dieguez, Carlos
López, Miguel
Müller, Timo D.
Varela-Rey, Marta
Douros, Jonathan D.
Nogueiras, Ruben https://orcid.org/0000-0002-9976-9930
Funding for this research was provided by:
Ministerio de Ciencia e Innovación (PID2021-126096NB-I00)
Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia (2021-CP085)
European Research Council (810331)
Article History
Received: 13 June 2024
Revised: 8 November 2024
Accepted: 11 November 2024
First Online: 28 November 2024
Declarations
:
: T.D.M. receives research funding from Novo Nordisk and has received speaking fees from Eli Lilly, AstraZeneca, Merck and Novo Nordisk.
: All experiments were carried out in accordance with Animal Ethics Committee at the University of Santiago de Compostela.
: All authors read and approved the submission and final publication.